Besides, in early cervical cancer, pancreatic cancer, and neuroblastoma, the level of B3GNT3 mRNA is higher than that of adjacent control tissues (Ho et al., 2013; Zhang et al., 2015; Barkley et al., 2018; Li et al., 2018). This evidence concerns the gene B3GNT3 and cervical carcinoma.